LOGO
LOGO

Corporate News

PolarityTE : Diabetic Foot Ulcer Trial Meets Primary And Secondary Endpoint

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

PolarityTE Inc. (PTE) said that a multi-center randomized controlled trial evaluating treatment of Diabetic Foot Ulcers with SkinTE plus standard of care compared to standard of care alone met the primary endpoint of wound closure at 12 weeks and secondary endpoint of Percent Area Reduction or PAR at 12 weeks.

The company said 100 patients were evaluated across 13 sites with 50 patients receiving SkinTE plus standard of care and 50 patients receiving standard of care alone.

The company noted that 70% of patients receiving SkinTE plus standard of care had wound closure at 12 weeks versus 34% of patients receiving standard of care alone.

PolarityTE said percent area reduction at 12 weeks was significantly greater for the SkinTE plus standard of care treatment group (84.4%) vs standard of care alone (53.5%).

For comments and feedback contact: editorial@rttnews.com

Business News

Global Economics Weekly Update -May 18 – May 22, 2026

May 22, 2026 14:46 ET
Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.

Latest Updates on COVID-19